← Insider buys
MCRB

Seres Therapeutics, Inc. · Healthcare

President and CEO Roger Pomerantz sold $1.7M of Seres Therapeutics, Inc.

Sold$1,692,705
$29.81Price
56,789Shares
−24%Stake

What MCRB did after the filing

Prices for MCRB after this filing aren't in yet.

Traded Fri, Jul 1. Filed Tue, Jul 5, 5:30 PM ET, after the close. Not investment advice.